Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Alector

    World Rank (Jan-05-2024)
    10,826
    Market Cap (Jan-05-2024)
    0.671 Billion USD
    World Rank (Jul-30-2023)
    12,352
    Market Cap (Jul-30-2023)
    0.531 Billion USD
    World Rank (Dec-25-2022)
    10,106
    Market Cap (Dec-25-2022)
    0.731 Billion USD
    World Rank (Jan-07-2022)
    7,536
    Market Cap (Jan-07-2022)
    1.46 Billion USD
    Annual Revenue in USD
    133 Million USD
    Annual Operating Income in USD
    -137 Million USD
    Annual Net Income in USD
    -133 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Alector is a Clinical Stage Biopharmaceutical company developing a broad portfolio of programs designed to empower the brains immune system to fight disease. It is having 78 employees as on 2019. The headquarters is in USA.
  2. Novavax

    World Rank (Jan-05-2024)
    11,359
    Market Cap (Jan-05-2024)
    0.613 Billion USD
    World Rank (Jul-30-2023)
    10,617
    Market Cap (Jul-30-2023)
    0.708 Billion USD
    World Rank (Dec-25-2022)
    9,445
    Market Cap (Dec-25-2022)
    0.821 Billion USD
    World Rank (Jan-07-2022)
    1,955
    Market Cap (Jan-07-2022)
    9.58 Billion USD
    Annual Revenue in USD
    1,598 Million USD
    Annual Operating Income in USD
    -664 Million USD
    Annual Net Income in USD
    -657 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Novavax is a Late Stage Biotechnology company that promotes improved global health through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company annual revenue is 157.0 million USD and 375 employees as on 2020. The headquarters is in USA.

  3. Fusion Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    11,376
    Market Cap (Jan-05-2024)
    0.611 Billion USD
    World Rank (Jul-30-2023)
    17,315
    Market Cap (Jul-30-2023)
    0.229 Billion USD
    World Rank (Dec-25-2022)
    19,740
    Market Cap (Dec-25-2022)
    0.145 Billion USD
    World Rank (Jan-07-2022)
    18,656
    Market Cap (Jan-07-2022)
    0.21 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -78 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Fusion Pharmaceuticals does research and works on Next-Generation Radiopharmaceuticals for precision medicine. Headquarters is in Canada.
  4. Allogene Therapeutics

    World Rank (Jan-05-2024)
    11,801
    Market Cap (Jan-05-2024)
    0.570 Billion USD
    World Rank (Jul-30-2023)
    10,537
    Market Cap (Jul-30-2023)
    0.718 Billion USD
    World Rank (Dec-25-2022)
    9,189
    Market Cap (Dec-25-2022)
    0.859 Billion USD
    World Rank (Jan-07-2022)
    6,446
    Market Cap (Jan-07-2022)
    1.92 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -335 Million USD
    Annual Net Income in USD
    -332 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Allogene Therapeutics is a Clinical Stage Biotechnology company. It single minded focus on pioneering the development of allogeneic chimeric antigen receptor T cell therapies for cancer and researchers is dedicated to discovery and translational research, development and cell manufacturing. The headquarters is in USA.
  5. Anavex Life Sciences

    World Rank (Jan-05-2024)
    12,167
    Market Cap (Jan-05-2024)
    0.536 Billion USD
    World Rank (Jul-30-2023)
    11,175
    Market Cap (Jul-30-2023)
    0.641 Billion USD
    World Rank (Dec-25-2022)
    10,700
    Market Cap (Dec-25-2022)
    0.659 Billion USD
    World Rank (Jan-07-2022)
    8,577
    Market Cap (Jan-07-2022)
    1.18 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -51 Million USD
    Annual Net Income in USD
    -48 Million USD
    Annual Results for Period Ending
    Sep-2022 ending year
    Headquarters Country
    Company Profile
    Anavex Life Sciences is a person-focused, biopharmaceutical company dedicated to therapeutic discovery and development of targeted CNS treatments. The headquarters is in USA.
  6. Voyager Therapeutics

    World Rank (Jan-05-2024)
    12,897
    Market Cap (Jan-05-2024)
    0.477 Billion USD
    World Rank (Jul-30-2023)
    14,213
    Market Cap (Jul-30-2023)
    0.395 Billion USD
    World Rank (Dec-25-2022)
    17,639
    Market Cap (Dec-25-2022)
    0.215 Billion USD
    World Rank (Jan-07-2022)
    22,338
    Market Cap (Jan-07-2022)
    0.11 Billion USD
    Annual Revenue in USD
    171 Million USD
    Annual Net Income in USD
    37 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  7. MeiraGTx Holdings

    World Rank (Jan-05-2024)
    13,314
    Market Cap (Jan-05-2024)
    0.446 Billion USD
    World Rank (Jul-30-2023)
    14,767
    Market Cap (Jul-30-2023)
    0.362 Billion USD
    World Rank (Dec-25-2022)
    16,414
    Market Cap (Dec-25-2022)
    0.269 Billion USD
    World Rank (Jan-07-2022)
    9,687
    Market Cap (Jan-07-2022)
    0.96 Billion USD
    Annual Revenue in USD
    37 Million USD
    Annual Net Income in USD
    -79 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    MeiraGTx Holdings is a Clinical Stage Gene Therapy company. It is focused on developing potentially curative treatments for patients living with serious diseases. The company annual revenue is 5.1 million USD and 155 full employees as on 2019. The headquarters is in USA.
  8. iTeos Therapeutics Inc.

    World Rank (Jan-05-2024)
    13,965
    Market Cap (Jan-05-2024)
    0.400 Billion USD
    World Rank (Jul-30-2023)
    12,768
    Market Cap (Jul-30-2023)
    0.499 Billion USD
    World Rank (Dec-25-2022)
    10,597
    Market Cap (Dec-25-2022)
    0.669 Billion USD
    World Rank (Jan-07-2022)
    7,393
    Market Cap (Jan-07-2022)
    1.52 Billion USD
    Annual Revenue in USD
    344 Million USD
    Annual Net Income in USD
    214 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    iTeos Therapeutics is a Clinical Stage Biopharmaceutical Company pioneering the discovery and development of a new generation of highly differentiated immuno oncology therapeutics for patients. It innovative pipeline includes two clinical stage programs targeting novel, validated immuno oncology pathways designed to build on prior learnings in the field to have differentiated pharmacological and clinical profiles. The headquarters is in USA.
  9. Fate Therapeutics

    World Rank (Jan-05-2024)
    14,336
    Market Cap (Jan-05-2024)
    0.379 Billion USD
    World Rank (Jul-30-2023)
    13,932
    Market Cap (Jul-30-2023)
    0.414 Billion USD
    World Rank (Dec-25-2022)
    8,052
    Market Cap (Dec-25-2022)
    1.070 Billion USD
    World Rank (Jan-07-2022)
    3,499
    Market Cap (Jan-07-2022)
    4.61 Billion USD
    Annual Revenue in USD
    55 Million USD
    Annual Net Income in USD
    -212 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Fate Therapeutics is a Clinical Stage Biopharmaceutical company. The company is dedicated to the development of next generation cellular immunotherapies for cancer and immune disorders. The headquarters is in USA.

  10. Orchard Therapeutics

    World Rank (Jan-05-2024)
    14,416
    Market Cap (Jan-05-2024)
    0.373 Billion USD
    World Rank (Jul-30-2023)
    22,193
    Market Cap (Jul-30-2023)
    0.091 Billion USD
    World Rank (Dec-25-2022)
    25,462
    Market Cap (Dec-25-2022)
    0.048 Billion USD
    World Rank (Jan-07-2022)
    20,128
    Market Cap (Jan-07-2022)
    0.16 Billion USD
    Headquarters Country
    Company Profile
    Orchard Therapeutics is Biotechnology sector company with headquarters is in UK.

Share

Ads